Evidence map›Paper›PMID 12417574›Full record

ArticleThe Journal of clinical investigation2002

P311 induces a TGF-beta1-independent, nonfibrogenic myofibroblast phenotype.

Desi Pan, Xiaoning Zhe, Sandhya Jakkaraju, Gregory A Taylor, Lucia Schuger

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. P311, a novel intrinsically disordered protein, regulates adipocyte development.Biochemical and biophysical research communications · 2019
    Article
  15. Article
  16. Article
  17. P311, Friend, or Foe of Tissue Fibrosis?Frontiers in pharmacology · 2018
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Desi PanDepartment of Pathology, Wayne State University, School of Medicine, Detroit, Michigan 48201, USA.
Xiaoning Zhe
Sandhya Jakkaraju
Gregory A Taylor
Lucia Schuger
Wayne State University · USDurham VA Medical Center · US

Funding

Taste and smell enhancement in older cancer patientsP60AG011268 · NIA · DUKE UNIVERSITY · PI COHEN, HARVEY JAY · 1992 to 2005
$5.8M
Laminin Domains Involved in Lung DevelopmentR37HL048730 · NHLBI · WAYNE STATE UNIVERSITY · PI SCHUGER, LUCIA · 2002 to 2011
$3.7M
Mechanisms of Bronchial MyogenesisR01HL067100 · NHLBI · WAYNE STATE UNIVERSITY · PI SCHUGER, LUCIA · 2001 to 2005
$1.4M
LAMININ DOMAINS INVOLVED IN LUNG DEVELOPMENTR01HL048730 · NHLBI · WAYNE STATE UNIVERSITY · PI SCHUGER, LUCIA · 1997 to 2001
$611k
LAMININ DOMAINS INVOLVED IN MOUSE LUNG DEVELOPMENTR29HL048730 · NHLBI · WAYNE STATE UNIVERSITY · PI SCHUGER, LUCIA · 1992 to 1996
–
NHLBI NIH HHS HL-48730NHLBI NIH HHS HL-67100NHLBI NIH HHS R01 HL048730NHLBI NIH HHS R01 HL067100NHLBI NIH HHS R29 HL048730NHLBI NIH HHS R37 HL048730NIA NIH HHS AG11268NIA NIH HHS P60 AG011268
6 · The paper itself

Abstract

P311, also called PTZ17, was identified by suppressive subtraction hybridization as potentially involved in smooth muscle (SM) myogenesis. P311 is an 8-kDa protein with several PEST-like motifs found in neurons and muscle. P311 transfection into two fibroblast cell lines, NIH 3T3 and C3H10 T1/2, induced phenotypic changes consistent with myofibroblast transformation, including upregulation of SM alpha-actin and SM22, induction of FGF-2, VEGF, PDGF, and PDGF receptors, upregulation of integrins alpha3 and alpha5, and increased proliferation rate. The P311-mediated changes differed, however, from the well-characterized myofibroblast in that P311 inhibited TGF-beta1, TGF-beta receptor 2, and TGF-beta1-activating MMP-2 and MMP-9, with the resultant decrease in collagen 1 and 3 expression. The effect of P311 on collagen was overcome by exogenous TGF-beta1, indicating that the cells were responsive to TGF-beta1 paracrine stimulus. In support of a role for P311 in vivo, immunohistochemical examination of human wounds showed P311 only in myofibroblasts and their activated precursors. To our knowledge, these studies are the first to implicate P311 in myofibroblast transformation, to demonstrate that transformation may occur independently of TGF-beta1, and to suggest that P311 may prevent fibrosis.

Indexed as

3T3 CellsAnimalsCell DifferentiationCollagenFibroblastsHumansMiceNerve Tissue ProteinsOncogene ProteinsPhenotypePlatelet-Derived Growth FactorTensile StrengthTransforming Growth Factor betaTransforming Growth Factor beta1CollagenNerve Tissue ProteinsNREP protein, humanOncogene ProteinsPlatelet-Derived Growth FactorTGFB1 protein, humanTgfb1 protein, mouseTransforming Growth Factor betaTransforming Growth Factor beta1

Identifiers

PMID12417574
PMCPMC151607
OpenAlexW2085251552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.